50,000 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Fifth Lane Capital LP

Key Points

• Fifth Lane Capital LP acquired 50,000 shares of Walgreens Boots Alliance, valued at approximately $558,000, making it the firm's 6th largest holding.
• Walgreens Boots Alliance recently reported EPS of $0.38 for the quarter, exceeding expectations, with total revenue reaching $38.99 billion.
• Wall Street analysts have a consensus rating of "Hold" for Walgreens Boots Alliance, with four sell ratings and a price target averaging $10.59.

Fifth Lane Capital LP acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 50,000 shares of the pharmacy operator's stock, valued at approximately $558,000. Walgreens Boots Alliance comprises about 2.4% of Fifth Lane Capital LP's portfolio, making the stock its 6th biggest holding.

Several other hedge funds and other institutional investors have also bought and sold shares of WBA. Colonial Trust Co SC lifted its stake in Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,297 shares in the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance in the first quarter valued at approximately $27,000. Curat Global LLC bought a new position in Walgreens Boots Alliance in the first quarter valued at approximately $27,000. Federated Hermes Inc. lifted its stake in Walgreens Boots Alliance by 135.8% in the first quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after buying an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC bought a new position in Walgreens Boots Alliance in the first quarter valued at approximately $43,000. Institutional investors own 58.59% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on WBA shares. Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating on the stock. Finally, UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Price Performance

WBA stock opened at $11.96 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $13.25. The firm has a market cap of $10.35 billion, a P/E ratio of -1.64, a P/E/G ratio of 1.42 and a beta of 0.80. The company's 50-day moving average price is $11.56 and its two-hundred day moving average price is $11.12.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. During the same period last year, the firm earned $0.63 EPS. The business's quarterly revenue was up 7.2% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.